Symbiotec Pharmalab Scheduled to Attend Avendus Spark Investor Conference
Symbiotec Pharmalab Ltd 路 Intimation 路 12 Nov 2026, 9:59 pm
Symbiotec Pharmalab Scheduled to Attend Avendus Spark Investor Conference Symbiotec Pharmalab Limited has informed exchanges that company officials will participate in the Avendus Spark Conference on 16th Nov'26 from 11:00 AM to 05:00 PM at Grand Hyatt, Mumbai. The interaction will involve Group and 1-on-1 meetings hosted by Avendus Spark. Discussions will rely strictly on publicly available information without sharing any unpublished price-sensitive information (UPSI).
Original exchange filing (PDF)
More announcements from Symbiotec Pharmalab Ltd
- Intimation regarding change in Corporate Identification Number (CIN) and Listing Status of the Company. 路 17 Nov 2026
- Transcript of the Earnings conference call for the Analysts and Investors for the Quarter and Half year ended 路 12 Nov 2026
- Pursuant to Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording of Conference Call for Analysts and Investors held on November .... 路 06 Nov 2026
- Symbiotec Signs 10 Year take or Pay Agreement to Manufacture Fermentation based alternative protein for EU Innovator 路 06 Nov 2026
- The Monitoring Agency report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the utilisation and application of funds raised through the IPO of the Company .... 路 06 Nov 2026
- The Investor release being issued by the company, for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- Pursuant to regulations 30 of the SEBI Listing Regulations, Investor Presentation on the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026. 路 06 Nov 2026
- Symbiotec Pharmalab Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
